|
Jan 11
|
Xeris (XERS) Up on Licensing Deal With Amgen to Develop Tepezza
|
|
Jan 10
|
SELLAS (SLS) Rises on FDA Fast Track Tag to Leukemia Candidate
|
|
Jan 10
|
GSK to Buy Private Biotech, Strengthen Respiratory Pipeline
|
|
Jan 9
|
Sarepta (SRPT) Rises on Solid Q4 and 2023 Preliminary Results
|
|
Jan 9
|
Corcept (CORT) Stock Rises on Upbeat Revenue Guidance for 2024
|
|
Jan 6
|
Puma Biotechnology Inc CEO Alan Auerbach Sells 41,396 Shares
|
|
Jan 4
|
Collegium (COLL) Shares Rise on Financial Outlook for 2024
|
|
Jan 4
|
Assertio (ASRT) Shares Fall as Dan Peisert Steps Down as CEO
|
|
Jan 3
|
C4 Therapeutics (CCCC) Gains 310% in 3 Months: Here's Why
|
|
Jan 3
|
Anavex (AVXL) Falls 35% on Mixed Rett Syndrome Study Results
|
|
Jan 3
|
Longboard Pharma (LBPH) Up on Upbeat Data From Epilepsy Study
|
|
Jan 2
|
Corcept (CORT) Falls on Loss of Korlym Patent Lawsuit to Teva
|
|
Dec 29
|
Amicus (FOLD) Banks on Galafold, Overdependence a Concern
|
|
Dec 28
|
Iovance (IOVA) Falls After Clinical Update on Lung Cancer Drug
|
|
Dec 28
|
Coherus (CHRS) Stock Rallies on FDA Nod for Udenyca Onbody
|
|
Dec 26
|
Senti Bio (SNTI) Rises as FDA Clears IND for Cancer Candidate
|
|
Dec 26
|
Cidara (CDTX) Up on EC Nod for Rezzayo in Invasive Candidiasis
|
|
Dec 22
|
Sanofi (SNY) Discontinues Tusamitamab Ravtansine Cancer Program
|
|
Dec 21
|
argenx (ARGX) Tanks on Top-Line Data From Pemphigus Study
|
|
Dec 20
|
Roche's (RHHBY) sBLA for Xolair Gets FDA Priority Review Tag
|